End of Zepbound Shortage Threatens $1 Billion Knockoff Weight-Loss Shot Industry [BNN Bloomberg (Canada)]
Novo Nordisk A/S (NVO)
Last novo nordisk a/s earnings: 2/5 01:31 am
Check Earnings Report
US:NYSE Investor Relations:
novonordisk.com/investors.html
Company Research
Source: BNN Bloomberg
Lilly is now able to produce enough of its blockbuster obesity and diabetes medicines that the nationwide shortage of Mounjaro and Zepbound is officially over. As a result, regulators can begin cracking down on the industry that sprang up overnight to make the copycat versions that quenched surging demand. The message from Scott Brunner, chief executive officer of the Alliance for Pharmacy Compounding, the industry's major trade group, to his members and stakeholders is to “immediately cease preparing and dispensing compounded copies of Mounjaro, Zepbound.” Thousands of patients came to rely on knockoff versions of drugs made with tirzepatide after shortages began as early as 2022. The US Food and Drug Administration allows compounding pharmacies to make copies during shortages, without conducting the rigorous studies typically required of pharmaceuticals. “I am absolutely terrified,” said Diann Smith, a 59-year-old nurse in Honolulu, who lost more than 60 pounds using the drug
Show less
Read more
Impact Snapshot
Event Time:
NVO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NVO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NVO alerts
High impacting Novo Nordisk A/S news events
Weekly update
A roundup of the hottest topics
NVO
News
- Novo Nordisk to invest $158 million in insulin plant in Brazil [Yahoo! Finance Canada]Yahoo! Finance Canada
- Novo Nordisk to invest $158 million in insulin plant in Brazil [Yahoo! Finance]Yahoo! Finance
- Eli Lilly's Mounjaro, Zepbound removed from FDA's shortage list [Yahoo! Finance]Yahoo! Finance
- CNBC Daily Open: October's gravity bringing stocks down [CNBC]CNBC
- Is Hims & Hers rally at risk as GLP-1 shortages ease? [Seeking Alpha]Seeking Alpha
NVO
Earnings
- 8/8/24 - Beat
NVO
Sec Filings
- 9/30/24 - Form 6-K
- 9/24/24 - Form 6-K
- 9/20/24 - Form 6-K
- NVO's page on the SEC website